Dube Michael P

EDGAR CIK 0002019493

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
VP, Chief Accounting Officer
Direct Buys
0
$0
0 Shares
Direct Sells
3
($104,363)
-7,501 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/01/2026
07/06/2026
Sell
-2,641 @ $16.78
 ($44,316) 66,886 (-3.80%) Direct
01/05/2026
01/07/2026
Sell
-2,989 @ $9.21
 ($27,529) 52,277 (-5.41%) Direct
10/01/2025
10/03/2025
Sell
-1,871 @ $17.38
 ($32,518) 55,266 (-3.27%) Direct